“…The first concerns BRI3BP (see above), the second addresses the cytosolic component(s), acting upstream of the hSnd2/hSnd3 receptor, and the third relates to the possible mechanism of hSnd2/hSnd3. The four protein targeting pathways, which can deliver precursor polypeptides to the ER membrane appear to share a common principle, namely that they comprise a cytosolic component or complex, which recognises SPs and TMHs in newly synthesized ER import substrates (SRP, TRC35/Ubl4A/Bag6/TRC40, Snd1 in yeast, PEX19), plus a heterodimeric membrane receptor for the cytosolic SP- and TMH-recognition component (SRα/β, Wrb/Caml, Snd2/Snd3, PEX3+possibly PEX16) (Ast et al, 2013; Borgese et al, 2019; Tirincsi et al, 2022; Pool, 2022). Notably, however, a functional human homolog of yeast Snd1, which was shown to interact with ribosomes, has not been identified, leaving open the question as to which component(s) act(s) upstream of hSnd2/hSnd3.…”